The Role of Senolytics in Osteoporosis
Biomolecules · 16.08.2025 · 15 (8) · 1176
DOI: 10.3390/biom15081176 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.08.2025. Verfasst von Erman Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310014, China. Hauptthemen laut MEDLINE: Osteoporosis, Senotherapeutics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cellular senescence is a fundamental contributor to numerous dysfunctions and degenerative diseases, including osteoporosis. In genetically modified and preclinical animal models, therapeutic strategies targeting persistent senescent cells have been shown to delay and prevent osteoporosis. Senolytics are a class of drugs or compounds designed to selectively eliminate senescent cells without adversely affecting normal cells. In this review, we focus on the role of senolytic agents in regulating bone metabolism and their potential in the treatment of osteoporosis. We discussed major types of senolytics, such as natural compounds, kinase inhibitors, Bcl-2 family inhibitors, inhibitors of the mouse double minute 2/p53 interaction, heat shock protein 90 inhibitors, p53-binding inhibitors, and histone deacetylase inhibitors. This review also highlights the progress of senolytics in clinical trials. However, clinical results diverge from preclinical evidence. Therefore, senolytics should be critically evaluated as a potential therapeutic strategy for osteoporosis, with further validation required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310014, China.
- Orthopedics Research Institute, Zhejiang University, Hangzhou 310027, China.
- Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou 310009, China.
- Clinical Research Center of Motor System Disease of Zhejiang Province, Hangzhou 310009, China.
- School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.
ORCID-Profile: Erman Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, E., Zhang, J., Chen, H., & Li, W. (2025). The Role of Senolytics in Osteoporosis. Biomolecules, 15(8), 1176. https://doi.org/10.3390/biom15081176
Vancouver
Chen E, Zhang J, Chen H, Li W. The Role of Senolytics in Osteoporosis. Biomolecules. 2025;15(8):1176. doi:10.3390/biom15081176
BibTeX
@article{Chen2025,
author = {Chen, Erman and Zhang, Jingjing and Chen, Han and Li, Weixu},
title = {The Role of Senolytics in Osteoporosis},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {8},
pages = {1176},
doi = {10.3390/biom15081176}
}
EUVIMED